IPO - NASDAQ:MRNA

Biotech company developing mRNA medicines for a wide range of diseases.
Founder(s)
Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, Noubar Afeyan
THEME(S)
No items found.
SECTOR(S)
Healthcare
Investment Stage
Growth
Company Status
IPO/Public
Perspectives

More about Moderna

No items found.